Indospicine is a non-protein amino acid isolated from the legume Indigofera spicata. It is a potent inhibitor of the enzyme arginase, which is responsible for the conversion of arginine to ornithine. Indospicine has been shown to cause a variety of toxic effects in animals, including liver damage, growth retardation, and infertility. It is studied for its potential as a therapeutic agent for the treatment of certain cancers and other diseases. Indospicine has also been investigated as a potential anti-parasite agent.'
indospicine: RN given refers to (S)-isomer
L-indospicine : An alpha-amino acid that is 2,7-diaminoheptanoic acid substituted by a imino group at position 7 (the 2S stereoisomer).
ID Source | ID |
---|---|
PubMed CID | 108010 |
CHEBI ID | 6253 |
SCHEMBL ID | 1512880 |
MeSH ID | M0162686 |
Synonym |
---|
C08288 |
l-indospicine |
16377-00-7 |
indospicine |
l-6-amidinonorleucine |
AC1L335Z , |
(2s)-2,7-diamino-7-iminoheptanoic acid |
AC1Q5QLR , |
CHEBI:6253 |
x29q4d9671 , |
6-amidino-2-aminohexanoic acid |
heptanoic acid, 2,7-diamino-7-imino-, (s)- |
unii-x29q4d9671 |
indospicine [mi] |
l-.alpha.-amino-.epsilon.-amidinocaproic acid |
SCHEMBL1512880 |
(2s)-2,7-diamino-7-imino-heptanoic acid |
DTXSID70167659 |
Q1661793 |
(2s)-2-amino-6-carbamimidoylhexanoic acid |
Indospicine is an arginine analogue and a natural toxin occurring only in Indigofera plant species, including Australian native species. It is a non-proteogenic amino acid that accumulates as the free amino acid in livestock grazing Indig ofera.
Excerpt | Reference | Relevance |
---|---|---|
"Indospicine has caused both primary and secondary hepatotoxicosis and also reproductive losses, but has only previously been determined in a small number of Indigofera species." | ( Seasonal and Species Variation of the Hepatotoxin Indospicine in Australian Indigofera Legumes As Measured by UPLC-MS/MS. Al Jassim, R; D'Arcy, BR; Fletcher, MT; Materne, CM; Silcock, RG; Tan, ET, 2016) | 1.41 |
Excerpt | Reference | Relevance |
---|---|---|
" Indospicine, a toxic amino acid found in the genus Indigofera, was detected in samples of suspect horsemeat." | ( Hepatotoxicity to dogs of horse meat contaminated with indospicine. Cameron, R; Hegarty, MP; Kelly, WR; McEwan, D; Williams, OJ, 1988) | 1.43 |
Role | Description |
---|---|
hepatotoxic agent | A role played by a chemical compound exihibiting itself through the ability to induce damage to the liver in animals. |
plant metabolite | Any eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms. |
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Class | Description |
---|---|
carboxamidine | Compounds having the structure RC(=NR)NR2. The term is used as a suffix in systematic nomenclature to denote the -C(=NH)NH2 group including its carbon atom. |
non-proteinogenic L-alpha-amino acid | Any L-alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (5.56) | 18.7374 |
1990's | 2 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 12 (66.67) | 24.3611 |
2020's | 3 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.34) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 1 (5.56%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 17 (94.44%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |